Description

Darzalex is a monoclonal antibody used in the treatment of multiple myeloma, a type of blood cancer. It works by targeting CD38, a protein found on the surface of myeloma cells, leading to their destruction.

Interpreter Notes

Interpreters may encounter variations of the term such as 'daratumumab' in discussions about the drug's mechanism or clinical trials. It is crucial to maintain a formal register when interpreting for healthcare professionals and avoid colloquial terms. Ensure that the context of use is clear, as Darzalex may be referenced in various treatment plans.

Example Sentences

EN: The doctor prescribed Darzalex to the patient as part of their treatment plan for multiple myeloma.

ES: El médico recetó Darzalex al paciente como parte de su plan de tratamiento para el mieloma múltiple.

Common Interpreter Mistakes

Confusing Darzalex with other monoclonal antibodies; mispronouncing Darzalex as if it were a generic term; mixing up treatment protocols associated with multiple myeloma.